January 15, 2014
This article was reported by Science Codex.
Science Codex reported the results of an Albert Einstein College of Medicine of Yeshiva University study of hepatitis C prevalence among US Hispanic groups. The study's analysis of data gathered for the National Institutes of Health (NIH)-funded Hispanic Community Health Study/Study of Latinos indicated hepatitis C infection varied widely among Hispanic groups and was much more likely among Puerto Rican Hispanics. The NIH study collected data on 11,964 Hispanic adults from the Bronx, Miami, Chicago, and San Diego.
The Albert Einstein study authors were unable to explain why hepatitis C prevalence was higher among Puerto Rican Hispanics. Lead Author Mark Kuniholm urged community-based campaigns to increase hepatitis C testing and treatment among Hispanics and to focus extra effort on communities with large Puerto Rican populations, such as the Bronx or Chicago.
In 2012, CDC recommended that baby boomers and people with increased risk have hepatitis C tests. The US Food and Drug Administration recently approved new hepatitis C medications that could cure more than 80 percent of hepatitis C infections.
The full report, "Prevalence of Hepatitis C Virus Infection in US Hispanic/Latino Adults: Results from the NHANES 20072010 and HCHS/SOL Studies," was published online in the Journal of Infectious Diseases (2014; doi: 10.1093/infdis/jit672).
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|How to Reverse Implicit Bias in HIV Care: 6 Steps to Take Today|
|PrEP Prescriptions Rise Sharply, but Unequally, in New York City|
|A Review of Late-Stage HIV Antiretroviral Candidates at IDWeek 2017|
|Free Your (and Carl's) Mind: An Open Letter to Anthony Fauci About HIV Prevention Research Priorities|
|Let's Advance the Conversation Among Black Women on HIV and PrEP|
|This Week in HIV Research: Injectable PrEP Shows Promise in New Study|